Personal Finance

Incyte Stock Is the S&P 500’s Top Performer. Here’s Why.

Shares of biopharmaceutical company

Incyte were on track Tuesday for their best trading session in more than six years.

Continue reading this article with a Barron’s subscription.

View Options

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button